Idiopathic Thrombocytopenia Purpura

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2019-07-05
Clinical Trial Update: A Long-term Safety Study of Eltrombopag in Pediatric Patients With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) [Phase 3]
Phase 3 long-term safety study of eltrombopag in pediatric patients with chronic idiopathic thrombocytopenic purpura completed; results post…